<code id='9A68CF8D9D'></code><style id='9A68CF8D9D'></style>
    • <acronym id='9A68CF8D9D'></acronym>
      <center id='9A68CF8D9D'><center id='9A68CF8D9D'><tfoot id='9A68CF8D9D'></tfoot></center><abbr id='9A68CF8D9D'><dir id='9A68CF8D9D'><tfoot id='9A68CF8D9D'></tfoot><noframes id='9A68CF8D9D'>

    • <optgroup id='9A68CF8D9D'><strike id='9A68CF8D9D'><sup id='9A68CF8D9D'></sup></strike><code id='9A68CF8D9D'></code></optgroup>
        1. <b id='9A68CF8D9D'><label id='9A68CF8D9D'><select id='9A68CF8D9D'><dt id='9A68CF8D9D'><span id='9A68CF8D9D'></span></dt></select></label></b><u id='9A68CF8D9D'></u>
          <i id='9A68CF8D9D'><strike id='9A68CF8D9D'><tt id='9A68CF8D9D'><pre id='9A68CF8D9D'></pre></tt></strike></i>

          explore

          explore

          author:hotspot    Page View:126
          Adobe

          Humana’s Medicare Advantage enrollees got care in the hospital and physician clinics way more often than the company predicted at the end of 2023, forcing the health insurance giant on Thursday to drastically slash its profit projections for both 2023 and 2024.

          Those higher medical costs will wipe away more than $775 million of profit that Humana had expected to bank for 2023. Humana also is “currently assessing the expected impact of emerging utilization trends on its 2024 outlook, which is anticipated to be material if current trends continue,” according to the company’s update to investors.

          advertisement

          Humana’s bad news for Wall Street didn’t end there: The company said it appears it only added just 100,000 new Medicare Advantage members from the most recent enrollment period that ended last month — down from estimates that it would enroll anywhere from 325,000 to 435,000 people.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          leisure time

          Alkermes shareholders re
          Alkermes shareholders re

          MarkLennihan/APAlkermesshareholdersvotedThursdaytore-electallofthedrugmaker’scurrentdirectors,ending

          read more
          Editas, Vertex strike deal on CRISPR
          Editas, Vertex strike deal on CRISPR

          AdobeForadecade,leadingacademicinstitutesandtheirassociatedcompaniesfoughtabruising,headline-grabbin

          read more
          Drug repurposing or repositioning? The language matters
          Drug repurposing or repositioning? The language matters

          AdobeFindinganewmedicineisnevereasy.Butdevelopingtreatmentsforpatientswithrarediseases—conditionstha

          read more

          Covid isolation guidance eased by the CDC

          ApersonquarantinedathomewithCovid-19looksoutfromherfrontdooronLongIsland,N.Y.JohnMoore/GettyImagesTh